Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...
Roblox Corporation reported a 51% year-over-year increase in bookings in its second quarter 2025. Click here to read why RBLX ...